Journal of Gastroenterology

, Volume 41, Issue 10, pp 1020–1022 | Cite as

Renin–angiotensin system and progression of chronic liver diseases

  • Hitoshi Yoshiji
  • Hiroshi Fukui


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Helmy, A, Jalan, R, Newby, DE, Hayes, PC, Webb, DJ 2000Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosisGastroenterology11856572PubMedCrossRefGoogle Scholar
  2. 2.
    Garcia-Pagan, JC, Bosch, J, Rodes, J 1995The role of vasoactive mediators in portal hypertensionSemin Gastrointest Dis61407PubMedGoogle Scholar
  3. 3.
    Bataller, R, Gines, P, Nicolas, JM, Gorbig, MN, Garcia-Ramallo, E, Gasull, X,  et al. 2000Angiotensin II induces contraction and proliferation of human hepatic stellate cellsGastroenterology118114956PubMedCrossRefGoogle Scholar
  4. 4.
    Bataller, R, Sancho-Bru, P, Gines, P, Lora, JM, Al-Garawi, A, Sole, M,  et al. 2003Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin IIGastroenterology12511725PubMedCrossRefGoogle Scholar
  5. 5.
    Bataller, R, Sancho-Bru, P, Gines, , Brenner, DA 2005Liver fibrogenesis: a new role for the renin-angiotensin systemAntioxid Redox Signal7134655PubMedCrossRefGoogle Scholar
  6. 6.
    Yoshiji, H, Kuriyama, S, Yoshii, J, Ikenaka, Y, Noguchi, R, Yanase, K,  et al. 2003Angiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis developmentHepatol Res27516PubMedCrossRefGoogle Scholar
  7. 7.
    Ikura, Y, Ohsawa, M, Shirai, N, Sugama, Y, Fukushima, H, Suekane, T,  et al. 2005Expression of angiotensin II type 1 receptor in human cirrhotic livers: its relation to fibrosis and portal hypertensionHepatol Res3210716PubMedCrossRefGoogle Scholar
  8. 8.
    Dixon, JB, Bhathal, PS, Jonsson, JR, Dixon, AF, Powell, EE, O'Brien, PE 2003Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obeseJ Hepatol3996771PubMedCrossRefGoogle Scholar
  9. 9.
    Powell, EE, Edwards-Smith, CJ, Hay, JL, Clouston, AD, Crawford, DH, Shorthouse, C,  et al. 2000Host genetic factors influence disease progression in chronic hepatitis CHepatology3182833PubMedCrossRefGoogle Scholar
  10. 10.
    Ueki, M, Koda, M, Yamamoto, S, Matsunaga, Y, Murawaki, Y 2006Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in ratsJ Gastroenterol419961004Google Scholar
  11. 11.
    Jonsson, JR, Clouston, AD, Ando, Y, Kelemen, LI, Horn, MJ, Adamson, MD,  et al. 2001Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosisGastroenterology12114855PubMedCrossRefGoogle Scholar
  12. 12.
    Ohishi, T, Saito, H, Tsusaka, K, Toda, K, Inagaki, H, Hamada, Y,  et al. 2001Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in ratsHepatol Res2114758PubMedCrossRefGoogle Scholar
  13. 13.
    Yoshiji, H, Kuriyama, S, Yoshii, J, Ikenaka, Y, Noguchi, R, Nakatani, T,  et al. 2001Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in ratsHepatology3474550PubMedGoogle Scholar
  14. 14.
    Yoshiji, H, Yoshii, J, Ikenaka, Y, Noguchi, R, Tsujinoue, H, Nakatani, T,  et al. 2002Inhibition of renin–angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in ratsJ Hepatol372230PubMedCrossRefGoogle Scholar
  15. 15.
    Kanno, K, Tazuma, S, Chayama, K 2003AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4)Biochem Biophys Res Commun30817783PubMedCrossRefGoogle Scholar
  16. 16.
    Yang, L, Bataller, R, Dulyx, J, Coffman, TM, Gines, P, Rippe, RA,  et al. 2005Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient miceJ Hepatol4331723PubMedCrossRefGoogle Scholar
  17. 17.
    Terui, Y, Saito, T, Watanabe, H, Togashi, H, Kawata, S, Kamada, Y,  et al. 2002Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis CHepatology361022PubMedCrossRefGoogle Scholar
  18. 18.
    Yokohama, S, Yoneda, M, Haneda, M, Okamoto, S, Okada, M, Aso, K,  et al. 2004Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitisHepatology4012225PubMedCrossRefGoogle Scholar
  19. 19.
    Rimola, A, Londono, MC, Guevara, G, Bruguera, M, Navasa, M, Forns, X,  et al. 2004Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantationTransplantation7868691PubMedCrossRefGoogle Scholar
  20. 20.
    Yoshiji, H, Kuriyama, S, Noguchi, R, Yoshii, J, Ikenaka, Y, Yanase, K,  et al. 2005Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis developmentLiver Int2515361PubMedCrossRefGoogle Scholar
  21. 21.
    Yoshiji, H, Noguchi, R, Kuriyama, S, Ikenaka, Y, Yoshii, J, Yanase, K,  et al. 2005Imatinib mesylate (STI-571) attenuates liver fibrosis development in ratsAm J Physiol Gastrointest Liver Physiol288G90713PubMedCrossRefGoogle Scholar
  22. 22.
    Carmeliet, P 2005Angiogenesis in life, disease and medicineNature4389326PubMedCrossRefGoogle Scholar
  23. 23.
    Yoshiji, H, Kuriyama, S, Fukui, H 2002Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factorTumour Biol2334856PubMedCrossRefGoogle Scholar
  24. 24.
    Yoshiji H, Kuriyama S, Noguchi R, Ikenaka Y, Kitade M, Kaji K, et al. Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development. Hepatol Res 2006 in pressGoogle Scholar
  25. 25.
    Yoshiji, H, Kuriyama, S, Yoshii, J, Ikenaka, Y, Noguchi, R, Hicklin, DJ,  et al. 2003Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesisGut52134754PubMedCrossRefGoogle Scholar
  26. 26.
    Suzuki, K, Hayashi, N, Miyamoto, Y, Yamamoto, M, Ohkawa, K, Ito, Y,  et al. 1996Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinomaCancer Res5630049PubMedGoogle Scholar
  27. 27.
    Yamaguchi, R, Yano, H, Iemura, A, Ogasawara, S, Haramaki, M, Kojiro, M 1998Expression of vascular endothelial growth factor in human hepatocellular carcinomaHepatology286877PubMedCrossRefGoogle Scholar
  28. 28.
    Hori, K, Saito, S, Takahashi, H, Sato, H, Maeda, H, Sato, Y 2000Tumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochlorideJpn J Cancer Res912619PubMedGoogle Scholar
  29. 29.
    Yoshiji, H, Kuriyama, S, Noguchi, R, Fukui, H 2004Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapyCurr Cancer Drug Targets455567PubMedCrossRefGoogle Scholar
  30. 30.
    Noguchi, R, Yoshiji, H, Kuriyama, S, Yoshii, J, Ikenaka, Y, Yanase, K,  et al. 2003Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesisClin Cancer Res9603845PubMedGoogle Scholar
  31. 31.
    Yoshiji, H, Kuriyama, S, Noguchi, R, Yoshii, J, Ikenaka, Y, Yanase, K,  et al. 2005Combination of vitamin K(2) and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppressionJ Hepatol4268793PubMedCrossRefGoogle Scholar
  32. 32.
    Frachon, S, Gouysse, G, Dumorti, J, Couvelard, A, Nejjari, M, Mion, F,  et al. 2001Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical studyJ Hepatol348507PubMedCrossRefGoogle Scholar
  33. 33.
    Mazzanti, R, Messerini, L, Monsacchi, L, Buzzelli, G, Zignego, AL, Foschi, M,  et al. 1997Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesisHepatology2522934PubMedCrossRefGoogle Scholar
  34. 34.
    Yoshiji, H, Kuriyama, S, Yoshii, J, Ikenaka, Y, Noguchi, R, Hicklin, DJ,  et al. 2004Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in miceHepatology39151724PubMedCrossRefGoogle Scholar
  35. 35.
    Yoshiji, H, Noguchi, R, Kuriyama, S, Yoshii, J, Ikenaka, Y, Yanase, K,  et al. 2005Suppression of renin-angiotensin system attenuates hepatocarcinogenesis via angiogenesis inhibition in ratsAnticancer Res25333540PubMedGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 2006

Authors and Affiliations

  • Hitoshi Yoshiji
    • 1
  • Hiroshi Fukui
    • 1
  1. 1.Third Department of Internal MedicineNara Medical UniversityKashiharaJapan

Personalised recommendations